Insider Transactions in Q2 2023 at Bio Cardia, Inc. (BCDA)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 23
2023
|
David Mc Clung Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,280
+3.06%
|
$8,560
$2.34 P/Share
|
|
Jun 23
2023
|
Peter Altman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,421
+1.44%
|
$12,842
$2.34 P/Share
|
|
Jun 23
2023
|
Simon H Stertzer Director |
BUY
Grant, award, or other acquisition
|
Direct |
64,212
+19.34%
|
$128,424
$2.34 P/Share
|
|
Jun 23
2023
|
Andrew Scott Blank Director |
BUY
Grant, award, or other acquisition
|
Direct |
64,212
+23.3%
|
$128,424
$2.34 P/Share
|
|
Jun 23
2023
|
Jim L. Allen Director |
BUY
Grant, award, or other acquisition
|
Direct |
64,212
+6.7%
|
$128,424
$2.34 P/Share
|
|
May 31
2023
|
Edward M Gillis Senior Vice President, Devices |
SELL
Payment of exercise price or tax liability
|
Direct |
15,512
-24.1%
|
$15,512
$1.77 P/Share
|
|
May 31
2023
|
Peter Altman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
36,821
-7.85%
|
$36,821
$1.77 P/Share
|
|
May 31
2023
|
David Mc Clung Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
20,676
-13.59%
|
$20,676
$1.77 P/Share
|
|
May 26
2023
|
Peter Altman President and CEO |
BUY
Open market or private purchase
|
Direct |
6,200
+1.3%
|
$6,200
$1.6 P/Share
|
|
May 18
2023
|
Peter Altman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
109,324
+19.1%
|
$109,324
$1.7 P/Share
|
|
May 18
2023
|
David Mc Clung Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
61,389
+28.75%
|
$61,389
$1.7 P/Share
|
|
May 18
2023
|
Edward M Gillis Senior Vice President, Devices |
BUY
Grant, award, or other acquisition
|
Direct |
40,490
+50.0%
|
$40,490
$1.7 P/Share
|